Classification and target spectrum
Various colony-stimulating factors differ in molecular weight, chromosomal gene localization, and the cells they act upon. The main producers are monocytes, macrophages, fibroblasts, and endothelial cells, with secretion increasing manifold under the action of bacterial products (via pattern recognition receptors) and pro-inflammatory cytokines.
- GM-CSF (chromosome 5q, 22 kDa). Activates a wide range of cells: macrophages, neutrophils, eosinophils, T cells, and dendritic cells. Unlike many other CSFs, it can additionally be synthesized by T and NK cells.
- G-CSF (chromosome 17q, 18–22 kDa). Targets predominantly neutrophils, eosinophils, T lymphocytes, and hematopoietic progenitor cells.
- M-CSF (chromosome 5q, 45/70 kDa). Exists as a dimeric molecule (membrane-bound or soluble). Stimulates macrophage development.
- Stem cell factor (SCF) (chromosome 12q, 32 kDa). Synonyms: stem cell factor, c-kit ligand. Produced by the bone marrow stroma. Maintains the viability of hematopoietic stem cells, critically important for erythropoiesis, mast cell development, and thymocyte development at the DN1 and DN2 stages. In pathology, it can serve as a growth factor for myeloblasts in leukemia.
- Flt-3 ligand (chromosome 19q, 26.4 kDa). Structurally and functionally close to SCF. Supports early myelopoiesis and B lymphocyte maturation.
Structural features of receptors
Signal transduction mechanisms depend on the structure of the factor molecules and their receptor apparatus.
Factors G-CSF, GM-CSF, and interleukin-3 (IL-3) are hematopoietins by structure—their molecules contain four $\alpha$-helical domains. Their receptors belong to the hematopoietin family and typically consist of two polypeptide chains (e.g., the $\alpha$ and $\beta$ chains of the GM-CSF receptor).
The M-CSF receptor is structured differently. It has extracellular immunoglobulin-like domains and an intracellular region with pronounced tyrosine kinase activity (proto-oncogene c-Fms). Upon factor binding, the receptors dimerize, leading to kinase activation.
A similar mechanism is characteristic of the stem cell factor. Its c-Kit receptor (structurally similar to c-Fms and Flt-3) also dimerizes and phosphorylates upon ligand binding. Intracellular signal transmission in this process involves PI3K and the MAP cascade.
Physiological role and clinical application
The main physiological effect of CSFs is the enhancement of myelopoiesis (primarily granulocytopoiesis) and the acceleration of the release of young cells into the periphery. In laboratory blood tests, this manifests as neutrophilic leukocytosis with a shift of the formula to the right, which is a classic sign of an inflammatory response.
Knowledge of colony-stimulating factor functions has enabled the creation of effective recombinant drugs based on G-CSF and GM-CSF. In clinical practice, they are used for two main purposes:
- Stimulation of granulocytopoiesis in patients following cytotoxic exposures (irradiation, chemotherapy courses).
- Mobilization of hematopoietic stem cells. This is necessary for the subsequent collection of harvested stem cell grafts, which are used to restore hematopoiesis during tumor therapy.
Related groups of immune regulators
In addition to colony-stimulating factors, other mediators play a crucial role in humoral regulation, such as chemokines and interferons.
Chemokines provide leukocyte chemotaxis to the focus of inflammation, serving as a basic component of innate immunity.
Interferons (IFNs) are an autonomous group of cytokines with pronounced antiviral activity. They were discovered in 1957 by A. Isaacs (A. Isaacs) and J. Lindemann (J. Lindemann) while studying the phenomenon of "viral interference"—non-specific cellular resistance. Later, type I and type II interferons were described. The discovery of regulatory functions in interferons made it possible to classify them as cytokines, and the cloning of their genes launched large-scale biotechnological production of therapeutic drugs. At the same time, IFN $\gamma$ acts as a factor of both innate and adaptive immunity.
Briefly: answers to topical questions
Which signaling molecules and cytokines activate the secretion of colony-stimulating factors by macrophages?
The secretion of colony-stimulating factors by macrophages is activated by various bacterial products and pro-inflammatory cytokines.
The main inducers of synthesis include:
- Bacterial products — lipopolysaccharide (LPS) and other pathogen components acting as natural ligands.
- Pro-inflammatory cytokines — specifically, interleukin-1 (IL-1), which directly regulates the production of granulocyte-macrophage colony-stimulating factor (GM-CSF).
Under the influence of these signaling molecules, the synthesis and secretion of colony-stimulating factors increase significantly.
Which receptors ensure the perception of bacterial products by CSF-producing cells?
The perception of bacterial products by colony-stimulating factor-producing cells is ensured by pattern recognition receptors.
A key role in this process is played by:
- Pattern recognition receptors (PRRs) — bind bacterial products, leading to a significant increase in the synthesis and secretion of factors.
- Toll-like receptors (TLRs) — a specific family of pattern recognition receptors through which monocytes and macrophages are activated under the action of lipopolysaccharide (LPS) and other pathogens.
To avoid confusing the main factors by their targets, pay attention to the first letters: G-CSF stimulates granulocytes (neutrophils), M-CSF stimulates macrophages, and GM-CSF acts on both lineages (granulocyte-macrophage).
Class and exam questions
What is the difference between the M-CSF receptor and receptors of other hematopoietins?
G-CSF and GM-CSF receptors consist of two polypeptide chains without intrinsic kinase activity. The M-CSF receptor (c-Fms) has built-in tyrosine kinase activity and contains Ig-like extracellular domains.
What do mutations in the stem cell factor (SCF) gene lead to?
In mice, the steel mutation causes hematopoiesis defects and coat color changes. It has been established that mutations disrupting the synthesis of the membrane-bound form of this factor lead to gross embryonic development defects.
How is a massive release of colony-stimulating factors reflected in a blood test?
A pattern of neutrophilic leukocytosis with a shift of the leukocyte formula to the right forms, which is associated with active stimulation of granulocytopoiesis and the release of immature cells into the bloodstream.
Why are G-CSF preparations used in oncology?
They are necessary for mobilizing stem cells and stimulating hematopoiesis, which is suppressed during aggressive courses of chemotherapy and radiation therapy.
What else to study on this topic
- Molecular mechanisms of signal transduction via PI3K and the MAP kinase cascade
- The role of c-Kit receptor mutations in the pathogenesis of oncological diseases
- The pathological role of SCF as a growth factor for leukemic myeloblasts
- Chemokines: types, receptors, and role in leukocyte migration
- Classification of interferons and mechanisms of their antiviral action
Master the entire topic in the "Immunology" course
This is a summary. The course covers everything tested in classes and exams.
- Comprehensive study guide on "Colony-Stimulating Factors" and 723 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 23 video lessons on the subject
Other topics in the "Innate Immunity" section
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.